CLENE
Updated 757 days ago
6550 South Millrock Drive, Suite G50 Salt Lake City, Utah 84121
We are a clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases to restore and protect neuronal health and function. Our nanotherapeutics target cellular energy impairments that are common to many diseases... Our team of visionary innovators and pharmaceutical executives have proven track-records of excellence, expertise, and willingness to push therapeutic development beyond its traditional bounds. Our approach implements elemental solutions to therapeutic challenges results in new opportunities and insights into the world's most challenging diseases. Our singular vision is to transform the treatment of neurodegenerative diseases that steal away peoples' lives, allowing people to thrive... At Clene Nanomedicine Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe' section..
Also known as: Clene Inc., Clene Nanomedicine Inc.
Associated domains: clenenanomedicines.com, clenepharmaceutical.com